Recon Strategy
Contact

Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Sector
All
NEJM opinion

A population health approach to value-based drug pricing

  • Biopharma , 
  • Payers
Working Paper   Summary Drug companies are naturally incentivized…

Read more